Diamond Biofund Inc. (TPE: 6901)
Taiwan
· Delayed Price · Currency is TWD 31.10
+0.45 (1.47%)
Jan 20, 2025, 1:30 PM CST
Diamond Biofund Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Other Revenue | -1,407 | -2,440 | 1,016 | 3,064 | 6,501 | -303.32 |
| Revenue | -1,407 | -2,440 | 1,016 | 3,064 | 6,501 | -303.32 |
| Revenue Growth (YoY) | - | - | -66.85% | -52.88% | - | - |
| Gross Profit | -1,407 | -2,440 | 1,016 | 3,064 | 6,501 | -303.32 |
| Selling, General & Admin | 161.03 | 148.18 | 101.92 | 64.27 | 404.44 | 64.46 |
| Operating Expenses | 170.88 | 158.03 | 113.39 | 76.13 | 404.44 | 64.46 |
| Operating Income | -1,578 | -2,598 | 902.24 | 2,988 | 6,097 | -367.78 |
| Interest Expense | -3.65 | -0.81 | -0.25 | -0.55 | -0.66 | -0.69 |
| Interest & Investment Income | 21.9 | 16.24 | 0.86 | 0.12 | - | - |
| Currency Exchange Gain (Loss) | - | - | - | - | -4.88 | - |
| Other Non Operating Income (Expenses) | -1.73 | -1.7 | -21.74 | -26.56 | - | -2.28 |
| Pretax Income | -1,561 | -2,584 | 881.12 | 2,961 | 6,091 | -370.76 |
| Income Tax Expense | - | -0.41 | 83.34 | 108.98 | 1.84 | 0.11 |
| Net Income | -1,561 | -2,583 | 797.78 | 2,852 | 6,090 | -370.87 |
| Net Income to Common | -1,561 | -2,583 | 797.78 | 2,852 | 6,090 | -370.87 |
| Net Income Growth | - | - | -72.02% | -53.17% | - | - |
| Shares Outstanding (Basic) | 850 | 779 | 749 | 949 | 674 | 674 |
| Shares Outstanding (Diluted) | 850 | 779 | 770 | 955 | 685 | 674 |
| Shares Change (YoY) | 12.81% | 1.21% | -19.41% | 39.43% | 1.55% | - |
| EPS (Basic) | -1.84 | -3.32 | 1.06 | 3.01 | 9.03 | -0.55 |
| EPS (Diluted) | -1.84 | -3.32 | 1.04 | 2.98 | 8.89 | -0.55 |
| EPS Growth | - | - | -65.14% | -66.46% | - | - |
| Free Cash Flow | -4,471 | -2,587 | 471.63 | -300.42 | -290.33 | -55.19 |
| Free Cash Flow Per Share | -5.26 | -3.32 | 0.61 | -0.31 | -0.42 | -0.08 |
| Dividend Per Share | - | - | 0.170 | 0.200 | 0.200 | - |
| Dividend Growth | - | - | -15.33% | 0% | - | - |
| Gross Margin | - | - | 100.00% | 100.00% | 100.00% | - |
| Operating Margin | - | - | 88.84% | 97.52% | 93.78% | - |
| Profit Margin | - | - | 78.55% | 93.08% | 93.67% | - |
| Free Cash Flow Margin | - | - | 46.44% | -9.81% | -4.47% | - |
| EBITDA | -1,573 | -2,597 | 903.57 | 2,990 | 6,099 | -365.94 |
| EBITDA Margin | - | - | 88.97% | 97.59% | 93.82% | - |
| D&A For EBITDA | 4.34 | 1 | 1.33 | 2.31 | 2.43 | 1.84 |
| EBIT | -1,578 | -2,598 | 902.24 | 2,988 | 6,097 | -367.78 |
| EBIT Margin | - | - | 88.84% | 97.52% | 93.78% | - |
| Effective Tax Rate | - | - | 9.46% | 3.68% | 0.03% | - |
Source: S&P Capital IQ. Standard template. Financial Sources.